SC13G

Company

Celldex Therapeutics, Inc.

Filed

February 28, 2008

Accession Number

0000905718-08-000270

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →